Biosplice Therapeutics stock
The P2P Price™ is a per-security, model-derived indicative estimate, calculated daily from a time-decayed, volume-weighted blend of Buying Interest, Selling Interest, and platform activity.
Buy Biosplice Therapeutics shares
Sign up to view historical activity trends and post Buying Interest. Join thousands of investors on the platform.
Buy sharesSell Biosplice Therapeutics shares
Use the platform to understand the potential price of your shares. List anonymously and pay zero user fees.
Sell sharesMarket activity
Stay informed of the latest listings and standing Buying Interest.
About Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
Biosplice Therapeutics last round details
Frequently asked questions
Biosplice Therapeutics is a privately held company. Accredited and institutional investors seeking exposure to pre-IPO companies can invest through the platform — post Buying Interest or connect with an existing listing, subject to the company's transfer policy.
In most cases, yes. Because these are private securities, purchases are subject to accreditation and the company's right of first refusal and final approval.
If you hold shares, you may be able to sell them by finding a buyer on the platform. Your ability to sell always depends on the class of shares, holding period, and the company's transfer restrictions.
As a private company, Biosplice Therapeutics has no public stock price. The P2P Price shown here is a model-derived indicative estimate; sign up to see live indications of interest and to connect with counterparties.
The last known valuation is $12B, from its most recent primary funding round. Private valuations are indicative and not publicly quoted.
No. Biosplice Therapeutics remains privately held and cannot be accessed on public exchanges. Accredited investors can access it through secondary software platforms like this one before an IPO.
Nothing on this page is an offer to buy or sell, or a solicitation of an offer, any security. Pricing is indicative — generated from platform activity, not a binding quote.